India to Yemen: Ceftriaxone Export Trade Route

The India to Yemen Ceftriaxone corridor is one of India's established pharmaceutical export routes, with 598 shipments documented worth a combined $13.0M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's ceftriaxone manufacturing sector.

Across 74 active suppliers, the average shipment value stands at $21.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with ceftriaxone's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 21.1%, placing it at rank #10 among India's top ceftriaxone export destinations globally.

On the import side, key buyers of Indian ceftriaxone in Yemen include AL JABAL DRUGS & MEDICAL APPLIANCES, AL JABAL DRUGS MEDICAL APPLIANCE, TO THE ORDER OF and 80 others. AL JABAL DRUGS & MEDICAL APPLIANCES is the single largest importer with 179 shipments valued at $3.5M USD.

India's ceftriaxone exports to Yemen are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 250 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 74 active exporters signals a competitive but concentrated market — buyers in Yemen benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, ZYDUS LIFESCIENCES LIMITED, MEDREICH LIMITED — together account for 56% of total trade value on this route. The average shipment value of $21.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ciplacef 1000 injection 1 gm ceftriaxone sodium injection powder 1000 mg and ciplacef 1000 injection 1gm (ceftriaxonesodium injection powder 1000mg)nos, suggesting that buyers in Yemen tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AL JABAL DRUGS & MEDICAL APPLIANCES is the largest importer with 179 shipments worth $3.5M USD — representing 27% of all ceftriaxone imports from India on this route. A total of 83 buyers are active on this corridor.